Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0416
+0.0400 (2,500.00%)
Sep 3, 2026, 4:00 PM EST
Affymax Market Cap
Affymax has a market cap or net worth of $3.1 million as of September 4, 2026. Its market cap has increased by 5,100.01% in one year.
Market Cap
3.10M
Enterprise Value
n/a
Revenue
42.00K
Ranking
n/a
PE Ratio
0.51
Stock Price
$0.04
ChartMarket Cap Chart
Since December 15, 2006, Affymax's market cap has decreased from 484.83M to 3.10M, a decrease of -99.36%. That is a compound annual growth rate of -22.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 3.10M | 5,100.01% |
| Dec 31, 2025 | 59.59K | - |
| Dec 31, 2024 | 59.59K | 33.33% |
| Dec 29, 2023 | 44.69K | -85.00% |
| Dec 30, 2022 | 297.96K | -33.33% |
| Dec 31, 2021 | 446.94K | -94.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ampio Pharmaceuticals | 207.88K |
| Endonovo Therapeutics | 180.76K |
| CNBX Pharmaceuticals | 160.58K |
| GB Sciences | 158.82K |
| Scorpius Holdings | 128.40K |
| Immunotech Laboratories | 114.99K |
| Synairgen | 110.27K |
| PaxMedica | 88.39K |